Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan High-Dose Dual Therapy vs Levofloxacin Concomitant Therapy for H. Pylori Eradication
NCT07624422Phase 4Not yet recruiting
- Sponsor
- Damascus Hospital
- Start
- Nov 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan in Helicobacter pylori infection, sponsored by Damascus Hospital. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07624422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07624422.